To further characterize the influenza vaccine–induced responses at the inductive site of the immune response, we asked whether LN follicle GC reactions were altered in IL-21–treated animals on day 14 after B1, the time point at which we observed improved vaccine responses among IL-21–treated animals (Figure 1E). The gene discussed is IL21; the disease is influenza.